Events

This talk will explore how artificial intelligence (ASI) could revolutionize clinical care, biomedical research, and health system operations. We’ll also examine the ethical, regulatory, and societal implications of integrating superintelligent systems into healthcare. Join us for an exciting discussion with leading experts on what the future may hold and how we can shape it responsibly.

With commercial healthcare prices remaining stubbornly opaque and variable, this session will model how price transparency policies offer employers a powerful tool to control rising healthcare costs and empower more informed purchasing decisions.

As Medicare Advantage plans expand their supplemental benefits to include caregiver support, this session will examine the emerging business models, implementation challenges, and the potential for meaningful impact on families navigating complex care needs.

With physician shortages in the US, particularly in primary care and in underserved areas, this panel will explore the extent to which new medical schools may be effective or stymied in resolving shortages.

This panel explores the business models emerging around caring for the dying—from hospice to home-based care, Medicare Advantage innovations, and PACE programs—and asks whether private innovation can align with public values.

As healthcare systems consolidate at unprecedented rates while simultaneously embracing value-based payment models, this session examines whether market concentration helps or hinders the delivery of high-quality, cost-effective care.

MIT's Amy Finkelstein and Stanford's Liran Einav present their provocative vision for replacing America's fragmented insurance system with universal, automatic coverage designed for security, equity, and simplicity.

With organ shortages claiming thousands of lives annually, this session explores whether carefully designed market mechanisms can increase donation rates while maintaining ethical standards and preventing exploitation.